DRL says taking corrective actions after FDA warning letter
DRL shares on Monday stumbled by 3.44 percent over previous close to Rs 3,504.60 on BSE.
Nov 09, 2015, 21:12 PM IST
Dr Reddy's gets USFDA warning for 3 drug plants; stock tanks
The company hopes for a re-audit of the three plants by USFDA
Nov 06, 2015, 16:30 PM IST
Dr Reddy's Lab to enter Japanese market through a partner
Pharmaceutical major Dr Reddy's Laboratories Tuesday said it has plans to enter Japanese market through partnerships for specific products.
May 12, 2015, 19:37 PM IST